COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space
16/12/2024
EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified [...]
EssilorLuxottica signe un accord pour acquérir le groupe Espansione et accélérer ainsi sa croissance dans le domaine de la med-tech
16/12/2024
EssilorLuxottica signe un accord pour acquérir le groupe Espansione et accélérer ainsi sa croissance dans le domaine de la med-tech EssilorLuxottica renforce son portefeuille d’instruments perfectionnés de santé [...]
Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty
16/12/2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for [...]
Journal of Clinical Oncology Publishes NXC-201 Positive Clinical Results in relapsed/refractory AL Amyloidosis
16/12/2024
Chimeric antigen receptor T-cell (CAR-T) cell therapy NXC-201 is a novel approach to treat relapsed/refractory AL Amyloidosis NXC-201 demonstrated compelling clinical activity, rapid and deep complete responses in frail [...]
HWH International Inc. announces a collaboration with Asia Business College to launch the Hapi Wealth Program in China in the 1st quarter of 2025.
16/12/2024
BETHESDA, MD, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH” or the “Company”) (Nasdaq: HWH) is pleased to announce a strategic partnership with Asia Business College to launch its Hapi Wealth program [...]
Healthcare Integrated Technologies, Inc. Welcomes Tim Brady as its Full-Time Chief Financial Officer
16/12/2024
Knoxville, Tennessee, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator in healthcare solutions, is proud to announce the December 1, 2024 appointment of Timothy [...]
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
16/12/2024
BOSTON and LONDON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) today announced the appointment of Torsten Hombeck, Ph.D. as Chief Financial Officer, effective December 16, 2024. Dr. Hombeck [...]
Epilepsy Foundation Elevates Leadership Team: Dr. Caitlin Grzeskowiak Named Chief Research and Innovation Officer, Dr. Jacqueline French Appointed Medical Director
16/12/2024
Grzeskowiak and French set to advance research and medical care for the epilepsy community through innovation and collaboration BOWIE, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud [...]
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
16/12/2024
LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year [...]
JenaValve Announces First Case for Inclusion in JENA-VAD Registry
16/12/2024
Registry seeks to evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System in patients with left ventricular assist devices (LVADs) and clinically significant aortic regurgitation IRVINE, Calif [...]
Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
16/12/2024
PALO ALTO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing the [...]
invIOs to present progress across oncology pipeline during JP Morgan Week 2025
16/12/2024
VIENNA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week activities in San Francisco, [...]
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
16/12/2024
The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), [...]
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Florida
16/12/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
BioSyent Announces Renewal of Normal Course Issuer Bid
16/12/2024
MISSISSAUGA, Ontario, Dec. 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of [...]
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
16/12/2024
PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
16/12/2024
CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
New InsiGHTS Trial of TransCon™ hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26
16/12/2024
- Results for all three TransCon hGH starting dose cohorts, in first clinical trial of an indication outside of growth hormone deficiency, showed a safety and tolerability profile comparable to daily somatropin - [...]
Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
16/12/2024
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for [...]

Pages